Elevance Health Inc.
ELV | NYSE
$398.05
-$4.38 (-1.09%)
At close: Sep 23, 2026, 3:43 PM ET
$398.56
+$0.51 (+0.13%)
After-hours:
Sep 23, 2026, 5:17 PM ET
Company Profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Key Executives
| Name | Position |
|---|---|
| Gail Koziara Boudreaux | President, Chief Executive Officer & Director |
| Erin Wessling | Executive VP & Chief Legal Officer |
| Mark Bradley Kaye | Executive Vice President & Chief Financial Officer |
| Charles Morgan Kendrick Jr. | EVP and President of Commercial & Specialty Health Benefits |
| Felicia Farr Norwood | Executive VP & Chief Health Benefits Officer |
| Julie Goon | Senior Vice President of Public Affairs |
| Nathan Allen Rich | Vice President of Investor Relations |
| Peter David Haytaian | Special Advisor |
| Ronald William Penczek | Senior Vice President, Controller & Chief Accounting Officer |
| Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 15, 2026 | 10-Q | Quarterly Report |
| Jul 15, 2026 | 8-K | Current Report |
| Jun 17, 2026 | 11-K | Filing |
| Jun 17, 2026 | 11-K | Filing |
| Jun 15, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
Elevance Health Inc.
| Country | United States |
| IPO Date | Oct 29, 2001 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Employees | 96,615 |
| CEO | Gail Koziara Boudreaux |
Contact Details
220 Virginia Avenue Indianapolis,
Indiana 46204 United States
Stock Details
| Ticker Symbol | ELV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001156039 |
| CUSIP Number | 036752103 |
| ISIN Number | US0367521038 |
| SIC Code | 6324 |
Recent News
- 14 days ago / benzinga.comElevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
- 30 days ago / gurufocus.comIs ELV Undervalued? DCF Says Worth $614
- 1 month ago / defenseworld.netBarden Capital Management Inc. Purchases New Stake in Elevance Health, Inc. $ELV
- 1 month ago / zacks.comElevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
- 1 month ago / defenseworld.netBallast Inc. Makes New Investment in Elevance Health, Inc. $ELV
- 2 months ago / businesswire.comElevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- 2 months ago / defenseworld.netElevance Health, Inc. $ELV Shares Acquired by Amundi
- 2 months ago / 247wallst.comStock Market Live July 28, 2028: S&P 500 (SPY) Struggling to Stay Green
- 2 months ago / defenseworld.netBessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELV
- 2 months ago / defenseworld.netElevance Health, Inc. (NYSE:ELV) Given Consensus Rating of “Moderate Buy” by Brokerages
Add to Watchlist
Select watchlists to add or remove ELV